General, 5.7 percent of new cases and 25.6 percent of previously treated cases were MDR tuberculosis, that was thought as disease with resistance to in least isoniazid and rifampin . Another 11.2 percent of patients with new situations and 16.1 percent of those with previously treated cases had resistance to either isoniazid or rifampin . Taking into account the actual proportion of treated patients among all individuals previously, approximately 1 of 4 individuals with tuberculosis had disease that was resistant to isoniazid, rifampin, or both, and 1 of 10 got MDR tuberculosis.The treatment effects on the incidence of type 2 diabetes were at least as solid after 24 months and a decade of follow-up as after 15 years. Finally, analyses of the procedure effects calculated from observed-plus-imputed result data at a decade and at 15 years yielded relative ramifications of diabetes treatment which were similar to those calculated based on observed data only . Subgroup Analyses In the control group, there was no difference in the incidence of type 2 diabetes between individuals who had tried to lose excess weight with professional guidance and those who had not received professional guidance .